GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Stem Holdings Inc (OTCPK:STMH) » Definitions » Gross Profit

Stem Holdings (Stem Holdings) Gross Profit : $-10.10 Mil (TTM As of Sep. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Stem Holdings Gross Profit?

Stem Holdings's gross profit for the three months ended in Sep. 2023 was $-11.78 Mil. Stem Holdings's gross profit for the trailing twelve months (TTM) ended in Sep. 2023 was $-10.10 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Stem Holdings's gross profit for the three months ended in Sep. 2023 was $-11.78 Mil. Stem Holdings's Revenue for the three months ended in Sep. 2023 was $-11.78 Mil. Therefore, Stem Holdings's Gross Margin % for the quarter that ended in Sep. 2023 was N/A%.

Stem Holdings had a gross margin of N/A% for the quarter that ended in Sep. 2023 => No sustainable competitive advantage

During the past 8 years, the highest Gross Margin % of Stem Holdings was 31.28%. The lowest was -99999999.99%. And the median was 26.25%.


Stem Holdings Gross Profit Historical Data

The historical data trend for Stem Holdings's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stem Holdings Gross Profit Chart

Stem Holdings Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Gross Profit
Get a 7-Day Free Trial 0.33 3.67 6.55 2.12 -

Stem Holdings Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.30 0.05 0.58 1.04 -11.78

Competitive Comparison of Stem Holdings's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Stem Holdings's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stem Holdings's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Stem Holdings's Gross Profit distribution charts can be found below:

* The bar in red indicates where Stem Holdings's Gross Profit falls into.



Stem Holdings Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Stem Holdings's Gross Profit for the fiscal year that ended in Sep. 2023 is calculated as

Gross Profit (A: Sep. 2023 )=Revenue - Cost of Goods Sold
=0 - 0
=0.00

Stem Holdings's Gross Profit for the quarter that ended in Sep. 2023 is calculated as

Gross Profit (Q: Sep. 2023 )=Revenue - Cost of Goods Sold
=-11.783 - 0
=-11.78

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-10.10 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Stem Holdings's Gross Margin % for the quarter that ended in Sep. 2023 is calculated as

Gross Margin % (Q: Sep. 2023 )=Gross Profit (Q: Sep. 2023 ) / Revenue (Q: Sep. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=-11.78 / -11.783
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Stem Holdings  (OTCPK:STMH) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Stem Holdings had a gross margin of N/A% for the quarter that ended in Sep. 2023 => No sustainable competitive advantage


Stem Holdings Gross Profit Related Terms

Thank you for viewing the detailed overview of Stem Holdings's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Stem Holdings (Stem Holdings) Business Description

Traded in Other Exchanges
Address
2201 NW Corporate Boulevard, Suite 205, Boca Raton, FL, USA, 33431
Stem Holdings Inc is involved in a cannabis business. The company is engaged in the manufacture, possession, sale, distribution, and branding of cannabis and its related products. Its brand includes TJ's Gardens; Yerba Buena; Cannavore; Dose-ology and Travis X James.
Executives
Matthew Cohen director, officer: CEO & CFO 1702 COSTA DEL SOL, BOCA RATON FL 33432
Brian John Hayek director 7012 GIRARD ST, MCLEAN VA 22101
Diener Robert Louis Benjamin director 41ULUA PLACE, HAIKU HI 96708
Dennis Suskind director ONE NORTH END AVENUE, WORLD FINANCIAL CENTER, NEW YORK NY 10282
Rajiv Raj director 438B WOBURN AVE, TORONTO A6 M5M1L7
Jessica Michelle Feingold director 3730 W. 24TH AVE, DENVER CO 80211
Lindy L Sinder director 408 BARGARA LANE, BRYN MAWR PA 19010
Garrett Martin Bender director 506 ANDREWS AVENUE, DELRAY BEACH FL 33483
Adam Berk director, officer: President 9370 GRAND ESTATES WAY, BOCA RATON FL 33496
Steven Shelly Hubbard director, officer: CFO 3496 FARIVIEW WAY, WEST LINN OR 97068